Undervalued based on future growth
Results
4
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
4 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
SQURPHARMA | ৳220.00 | 0.1% | -4.2% | ৳195.6b | ৳352.20 | 7.5 | 11.4% | 5.5% | Pharmaceuticals & Biotech | ||
BXPHARMA | ৳145.80 | -3.4% | 24.9% | ৳64.7b | ৳183.37 | 7.5 | 12.5% | 3.3% | Pharmaceuticals & Biotech | ||
RENATA | ৳472.40 | 0.5% | -5.6% | ৳54.3b | ৳615.05 | 19.8 | 30.0% | 1.2% | Pharmaceuticals & Biotech | ||
BSCPLC | ৳156.10 | -1.5% | 3.3% | ৳29.2b | ৳162.80 | 10.2 | 27.1% | 2.6% | Telecom |
Page 1 of 1